These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23897442)

  • 1. Therapy. New mechanisms of IVIg.
    Leah E
    Nat Rev Rheumatol; 2013 Sep; 9(9):504. PubMed ID: 23897442
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 23840006.
    Wiedeman AE; Elkon KB
    Arthritis Rheumatol; 2014 Aug; 66(8):2309-10. PubMed ID: 24782278
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-α inhibition by intravenous immunoglobulin is independent of modulation of the plasmacytoid dendritic cell population in the circulation: comment on the article by Wiedeman et al.
    Sharma M; Saha C; Schoindre Y; Gilardin L; Benveniste O; Kaveri SV; Bayry J
    Arthritis Rheumatol; 2014 Aug; 66(8):2308-9. PubMed ID: 24782250
    [No Abstract]   [Full Text] [Related]  

  • 4. Sweets are good for you: fine tuning antibodies via glycosylation.
    Nigrovic PA
    Arthritis Rheum; 2013 Oct; 65(10):2541-4. PubMed ID: 23839979
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists.
    Wiedeman AE; Santer DM; Yan W; Miescher S; Käsermann F; Elkon KB
    Arthritis Rheum; 2013 Oct; 65(10):2713-23. PubMed ID: 23840006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.
    Trinath J; Hegde P; Sharma M; Maddur MS; Rabin M; Vallat JM; Magy L; Balaji KN; Kaveri SV; Bayry J
    Blood; 2013 Aug; 122(8):1419-27. PubMed ID: 23847198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.
    Maddur MS; Kaveri SV; Bayry J
    Trends Immunol; 2017 Nov; 38(11):789-792. PubMed ID: 28916232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of dendritic cells and regulatory T cells by naturally occurring antibodies.
    Kwekkeboom J
    Adv Exp Med Biol; 2012; 750():133-44. PubMed ID: 22903671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
    Burns JC; Song Y; Bujold M; Shimizu C; Kanegaye JT; Tremoulet AH; Franco A
    Clin Exp Immunol; 2013 Dec; 174(3):337-44. PubMed ID: 23901839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
    Maddur MS; Stephen-Victor E; Das M; Prakhar P; Sharma VK; Singh V; Rabin M; Trinath J; Balaji KN; Bolgert F; Vallat JM; Magy L; Kaveri SV; Bayry J
    J Neuroinflammation; 2017 Mar; 14(1):58. PubMed ID: 28320438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
    Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
    Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.
    Pau E; Cheung YH; Loh C; Lajoie G; Wither JE
    PLoS One; 2012; 7(5):e36761. PubMed ID: 22574220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?
    Sordé L; Spindeldreher S; Palmer E; Karle A
    Immun Inflamm Dis; 2017 Dec; 5(4):400-415. PubMed ID: 28560793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.
    Burns JC; Franco A
    Expert Rev Clin Immunol; 2015; 11(7):819-25. PubMed ID: 26099344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of innate immunity in the induction of autoimmunity.
    Pisetsky DS
    Autoimmun Rev; 2008 Oct; 8(1):69-72. PubMed ID: 18708168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
    Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcγ receptor IIb on CD11c(+) dendritic cells in a murine model.
    Yamamoto M; Kobayashi K; Ishikawa Y; Nakata K; Funada Y; Kotani Y; Masuda A; Takai T; Azuma T; Yoshida M; Nishimura Y
    Clin Exp Immunol; 2010 Nov; 162(2):315-24. PubMed ID: 20819092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
    Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.